Authors: SIDRANSKY E TAYEBI N STUBBLEFIELD BK ELIASON W KLINEBURGESS A PIZZOLATO GP COX JN PORTA J BOTTANI A DELOZIERBLANCHET CD

Citation: E. Sidransky et al., THE CLINICAL, MOLECULAR, AND PATHOLOGICAL CHARACTERIZATION OF A FAMILY WITH 2 CASES OF LETHAL PERINATAL TYPE-2 GAUCHER DISEASE, Journal of Medical Genetics, 33(2), 1996, pp. 132-136

Authors: TAYEBI N STUBBLEFIELD B ELIASON W KLINEBURGESS A GINNS EI SIDRANSKY E

Citation: N. Tayebi et al., MOLECULAR ANALYSIS OF SEVERE TYPE-2 GAUCHER DISEASE, Pediatric research, 37(4), 1995, pp. 153-153

Authors: SIDRANSKY E STUBBLEFIELD BK ELIASON W MARTIN BM GINNS EI

Citation: E. Sidransky et al., SEVERE NEONATAL GAUCHERS-DISEASE IN MICE AND HUMANS, Neurology, 44(4), 1994, pp. 10000347-10000347

Authors: SIDRANSKY E MARTIN BM ELIASON W GALDZICKA M FISHERMAN J CHO M LEE C GILBERT C SHORR R GINNS EI

Citation: E. Sidransky et al., PRECLINICAL STUDIES WITH POLYETHYLENE-GLYCOL MODIFIED GLUCOCEREBROSIDASE AS A POTENTIAL THERAPY FOR GAUCHER PATIENTS, Blood, 82(10), 1993, pp. 10000513-10000513

Authors: MCKINNEY C SIDRANSKY E MARTIN BM ELIASON W GALDZICKA M CHO M LEE S GILBERT C SHORR R GINNS EI

Citation: C. Mckinney et al., POLYETHYLENE-GLYCOL MODIFIED GLUCOCEREBROSIDASE - RESULTS FROM PRECLINICAL STUDIES, American journal of human genetics, 53(3), 1993, pp. 103-103